In addition to blocking MDM2-mediated degradation of RUNX3, the higher resulting levels of p53 may also sustain RUNX3 in a tumor suppressive state, as p53 dysregulation is likely a switch for RUNX3 to become oncogenic [10,11]. This evidence concerns the gene TP53 and neoplasm.